A window of opportunity: Maximizing the effectiveness of new HCV regimens in the United States with the expansion of the affordable care act
Author
Abstract
Suggested Citation
DOI: 10.2105/AJPH.2014.302327
Download full text from publisher
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Donald E. Bailey Jr. & Andrew J. Muir & Judith A. Adams & N. Marcus Thygeson & Hants Williams & Michael P. Cary Jr. & Ruth A. Anderson, 2019. "Clinical Encounters and Treatment Initiation for Chronic Hepatitis C Patients: Applications of Adaptive Leadership Framework for Chronic Illness," SAGE Open, , vol. 9(1), pages 21582440188, January.
More about this item
Keywords
antivirus agent; fused heterocyclic rings; simeprevir; sofosbuvir; sulfonamide; uridine phosphate; adult; analogs and derivatives; comorbidity; drug approval; drug combination; economics; genetics; genotype; health care delivery; health care policy; health survey; hepatitis B; Hepatitis C; Chronic; HIV Infections; human; insurance; legislation and jurisprudence; Mental Disorders; poverty; prevalence; risk factor; standards; substance abuse; trends; United States; Adult; Antiviral Agents; Comorbidity; Drug Approval; Drug Therapy; Combination; Genotype; Health Services Accessibility; Hepatitis B; Hepatitis C; Chronic; Heterocyclic Compounds; 3-Ring; HIV Infections; Humans; Insurance Coverage; Mental Disorders; Patient Protection and Affordable Care Act; Population Surveillance; Poverty; Prevalence; Risk Factors; Substance Abuse; Intravenous; Sulfonamides; United States; Uridine Monophosphate;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:10.2105/ajph.2014.302327_5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.